Abeona Therapeutics (ABEO) FCF Margin (2011 - 2026)

Abeona Therapeutics' FCF Margin history runs 13 years deep, the most recent figure standing at 237.83% for Q1 2026.

• In Q1 2026, FCF Margin changed N/A year-over-year to 237.83%; the TTM figure through Mar 2026 stood at 586.22% (changed N/A YoY), while the FY2025 annual figure was 1448.47%, changed N/A from the prior year.
• FCF Margin was 237.83% for Q1 2026 at Abeona Therapeutics, up from 352.51% in the prior quarter.
• In the past five years, FCF Margin ranged from a high of 237.83% in Q1 2026 to a low of 20613.24% in Q4 2022.
• Historically, FCF Margin has averaged 4543.77% across 4 years, with a median of 901.3% in 2022.
• Biggest YoY gain for FCF Margin was 60656 bps in 2023; the steepest drop was 60656 bps in 2023.
• A 4-year view of FCF Margin shows it stood at 20613.24% in 2022, then surged by 99 bps to 294.74% in 2023, then declined by 20 bps to 352.51% in 2025, then surged by 33 bps to 237.83% in 2026.
• The last three FCF Margin figures came in at 237.83% (Q1 2026), 352.51% (Q4 2025), and 5421.25% (Q2 2025), per Business Quant data.